Condition: Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer · Metastatic Gastric Adenocarcinoma or Cancer · Sponsor: Astellas Pharma Korea, Inc.
This study is for people in South Korea who have cancer in or around the stomach (gastric cancer) or cancer where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Their cancer is locally advanced, unresectable, or metastatic. Locally advanced means the cancer has spread to tissue close by. Unresectable means the cancer cannot be removed by surgery. Metastatic means the cancer has spread to other parts of the body. In South Korea, VYLOY is approved for the treatment of gastric cancer or GEJ cancer. The people in this study will receive VYLOY as part of their usual treatment for their cancer. In standard clinical practice VYLOY is given to people slowly through a tube into a vein. The main aim of the study is to collect information in a real-world setting about the safety of VYLOY in people with gastric cancer or GEJ cancer in clinics in South Korea. This study will also help researchers learn how long people's gastric cancer or GEJ cancer stays stable. This study is about collecting information only. This is known as an observational study. The individual's doctor decides on treatment, not the sponsor (Astellas). The study will last about 1 year (54 weeks).
This description comes directly from the study's public registry record.
Astellas Pharma Global Development, Inc. · 800-888-7704 · astellas.registration@astellas.com
Always discuss trial participation with your own doctor first.
| KR82010 | Goyang-si, Gyeonggi-do, South Korea | Recruiting |
| KR82008 | Suwon, Gyeonggi-do, South Korea | Recruiting |
| KR82009 | Suwon, Gyeonggi-do, South Korea | Recruiting |
| KR82006 | Yangsan, Gyeongsangnam-do, South Korea | Recruiting |
| KR82012 | Hwasun Gun, Jeollanam-do, South Korea | Recruiting |
| KR82001 | Seoul, South Korea | Recruiting |
| KR82002 | Seoul, South Korea | Recruiting |
| KR82003 | Seoul, South Korea | Recruiting |
| KR82004 | Seoul, South Korea | Recruiting |
| KR82005 | Seoul, South Korea | Recruiting |
| KR82007 | Seoul, South Korea | Recruiting |
| KR82011 | Seoul, South Korea | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06902545